Theralase Technologies Inc.
TSX VENTURE : TLT

Theralase Technologies Inc.

July 06, 2011 08:00 ET

Theralase Announces Appointments to U.S. Medical and Scientific Advisory Board

Elite practitioner group agrees to serve as medical advisors as Theralase expands into US market

TORONTO, ONTARIO--(Marketwire - July 6, 2011) - Theralase Technologies Inc. (TSX VENTURE:TLT) is pleased to announce the appointment of Dr. James R. Andrews as Chairman to its Medical and Scientific Advisory Board. Further appointments include senior medical orthopaedic practitioners and healthcare specialists from the renowned American Sports Medicine Institute (ASMI) and Andrews Sports Medicine & Orthopaedic Center located in Birmingham, Alabama (ASMOC). Andrews Sports Medicine & Orthopaedic Center, founded by Dr. Andrews, is a specialized North American facility widely recognized throughout the world for the treatment of a full range of orthopaedic sports injuries. ASMI is a world renowned sports medicine research and education foundation. Joining Dr. Andrews as Advisory Board appointees are medical and physiotherapy specialists from ASMI, including: Dr. Lyle Cain, Dr. Jeffrey Dugas, Kevin Wilk, DPT and Lanier Johnson.

Dr. James Andrews, ASMI Chairman and Medical Director, is internationally recognized for his 48 years of scientific and clinical research in orthopaedic surgical practice, specializing in knee, shoulder and elbow sports injuries. Dr. Andrews is the Senior Orthopaedic and Medical Consultant to many collegiate and professional sports teams and has served on the Sports Medicine Committee of the United States Olympic Committee. He is a past president of the American Orthopaedic Society for Sports Medicine. He also serves as a Director of several public and private medical and business corporations.

Dr. Lyle Cain is a 1994 graduate of the University of Alabama Medical School, a practicing orthopaedic surgeon, Fellowship Director and a senior staff member of ASMI. Dr. Cain serves as an orthopaedic consultant to collegiate and professional sports teams and is a member of a wide range of professional orthopaedic medical committees and institutes, including: the American Medical Association, the American Academy of Orthopaedic Surgeons, the American Orthopaedic Society for Sports Medicine and the International Cartilage Repair Society.

Dr. Jeffrey Dugas is a 1994 graduate of the Duke University School of Medicine, a practicing orthopaedic surgeon, Fellowship Director and a senior staff member of ASMI. Dr. Dugas serves as an orthopaedic consultant to collegiate and professional teams. Dr. Dugas has been widely published in medical journals for clinical studies on orthopaedic surgery and sports medicine injuries. He has received numerous awards and honors in his specialized field of orthopaedics and sports medicine and is a member of many professional medical organizations, including: the American Medical Association, American Medical Society for Sports Medicine, American Orthopaedic Society for Sport Medicine, American Academy of Orthopaedic Surgeons, the American Society for Shoulder and Elbow Surgery, and the International Cartilage Repair Society.

Kevin Wilk, DPT, holds a Doctorate in Physical Therapy from the Massachusetts General Health Institute of Boston, following 22 years as a practicing physical therapist. Since 1999, Dr. Wilk has been an Affiliate Member of the American Orthopaedic Society for Sports Medicine and since 1984 a Member of the Sections for Sports Medicine, Orthopaedics and Research of the American Physical Therapy Association. He is currently the President of the Sports Physical Therapy Section of the APTA. He is widely published in the fields of sports medicine and orthopaedic rehabilitation and is currently involved in numerous clinical studies and projects in the field of orthopaedic and sports physical therapy.

Lanier Johnson has a BS degree from the University of Alabama and a MBA from Auburn University. Mr. Johnson has been associated with Dr. Andrews and ASMI since 1990 and currently serves as the executive director of ASMI. Mr. Johnson has many years of management experience in the practice of sports medicine professional services and the development of comprehensive facilities for the practice of Sports Medicine. Mr. Johnson is the architect and developer of the Sports Medicine / Fitness Program and Traveling Van Facility for the PGA Tour.

Roger Dumoulin-White, President and CEO of Theralase Technologies Inc. stated, "We are delighted that Dr. Andrews, Dr. Cain, Dr. Dugas, Kevin and Lanier have agreed to be reappointed to the Theralase Medical and Scientific Advisory Board for another 5 years. They are an elite team of professionals who are able to help guide Theralase in the expansion of our world class therapeutic medical laser technology into the US medical market. We are looking forward to working hand in hand with the whole team as we dramatically increase our sales in the US medical market in 3Q 2011 and beyond.

James Andrews, MD, Andrews Sports Medicine & Orthopaedic Center Birmingham, Alabama stated, "Our rehab specialists have reported outstanding success when using the Theralase therapeutic laser system for rehabilitation of certain shoulder, knee, elbow and other neuromuscular skeletal conditions. The Theralase laser is now a standard of care treatment methodology within our rehab clinics and is a great tool in helping our athletes return to competition."

Lyle Cain MD, Andrews Sports Medicine & Orthopaedic Center stated, "I have recommended the Theralase laser for many soft tissue conditions of the shoulder, knee, elbow and other traumatic injuries. The Theralase laser has been an excellent adjunct to treatment by our physical therapies in our clinic and has been successful not only in treating athletes, but also the general population with injuries of the joints. The laser has been an excellent tool to help provide a healing response and to help the body heal these injuries."

Jeff Dugas MD, Andrews Sports Medicine & Orthopaedic Center stated, "We believe in Theralase technology and recommend its use to our patients. With very minimal to no risk, this modality makes sense in the treatment of many of the commonly encountered sports medicine conditions."

Kevin Wilk, DPT, Champion Sports Medicine, Birmingham, Alabama stated, "We are extremely confident in the efficacy of Theralase laser technology… in so much that we incorporate it in our daily treatment of nearly every patient… I really love the Theralase and my patients love it!"

About Theralase Technologies Inc.

Theralase Technologies Inc. designs, develops, manufactures and markets patented, superpulsed laser technology utilized in biostimulation and biodestruction applications. The technology is safe and effective in the treatment of chronic pain, neural muscular-skeletal conditions and wound care. When combined with its patented, light sensitive Photo Dynamic Compounds (PDCs), Theralase laser technology is able to specifically target and destroy cancer cells, bacteria and viruses.

This press release contains forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation to update these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

Contact Information